MULROY DENNIS (Chief Financial Officer) received a stock award from LA JOLLA PHARMACEUTICAL CO
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/17/2020ACC: 0000920465-20-000051
Officer· Chief Financial Officer
Since Oct 2018
+116.00
Net shares
Net buyer
$325.38
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
116.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+58.00
Price / share
$5.61
Trade value
$325.38
% of position
1.2%
4/15/2020
4.82K→4.88K
Total
Net shares
+58.00
Net value
$325.38
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2020 | A · Award | +58.00 | $5.61 | $325.38 | 1.2% | 4.82K | 4.88K |
| Total | +58.00 | $325.38 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
58.00 shares
Shares
+58.00
Strike price
6.6
Held after
58.00
Exercisable
—
4/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock58.00 shares | 4/15/2020 | A · Award | +58.00 | 6.6 | — | 58.00 |